Javascript must be enabled to continue!
Identification of an aprotinin antiviral domain
View through CrossRef
Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments. Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity. One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3. It consisted of the hexapeptide Y‐F‐Y‐N‐A‐K corresponding to amino acids 21–26 of intact aprotinin. An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity. Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J. Appl. Bact. 72, 180–187].
Title: Identification of an aprotinin antiviral domain
Description:
Digestion of the proteinase inhibitor aprotinin, by clostripain, a cysteine proteinase, yielded five oligopeptide fragments.
Two fragments exhibited both antiviral and antibacterial activities, two fragments only antiviral activity, and one fragment showed no antimicrobial activity.
One of the former oligopeptides showed antiviral activity against human herpes simplex virus type 1 and bovine parainfluenza virus type 3.
It consisted of the hexapeptide Y‐F‐Y‐N‐A‐K corresponding to amino acids 21–26 of intact aprotinin.
An identical synthetic peptide had the same antiviral spectrum as the natural hexapeptide, exhibited no antibacterial activity, and was also devoid of trypsin inhibiting activity.
Intact aprotinin, in contrast, is ineffective against human herpes simplex virus 1 and bovine parainfluenza virus 3 but possesses antibacterial properties against several bacterial species [(1992) J.
Appl.
Bact.
72, 180–187].
Related Results
Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass
Aprotinin protects the cerebral microcirculation during cardiopulmonary bypass
Background and objective: We have previously reported that administration of aprotinin at a single dose protects the cerebral microcirculation. The current study was designed to id...
The possibility of using silochrome sorbents for proteinase inhibitor aprotinin
The possibility of using silochrome sorbents for proteinase inhibitor aprotinin
Background. Aprotinin is a polypeptide, a proteinase inhibitor of natural origin. It inhibits kallikrein, kininogenase, plasmin, trypsin, chymotrypsin; blocks the activator of prof...
Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection
Network controllability analysis reveals the antiviral potential of Etravirine against Hepatitis E Virus infection
Abstract
Hepatitis E virus (HEV) is a major cause of acute viral hepatitis in lower- and middle-income countries. HEV infection may lead to acute...
Pharmaceutical Potential of Pyrimidines as Antiviral Agents
Pharmaceutical Potential of Pyrimidines as Antiviral Agents
Antiviral drugs are a class of medicines particularly used for the treatment of
viral infections. Drugs that combat viral infections are called antiviral drugs. Viruses
are among t...
The association of prokaryotic antiviral systems and symbiotic phage communities in drinking water microbiomes
The association of prokaryotic antiviral systems and symbiotic phage communities in drinking water microbiomes
Abstract
Prokaryotic antiviral systems are important mediators for prokaryote-phage interactions, which have significant implications for the survival of prokaryotic...
Antiviral Potential Efficacy of Green-Synthesized Silver and Titanium Dioxide Nanoparticles Against Rotavirus, Cytomegalovirus, and Human Papillomavirus
Antiviral Potential Efficacy of Green-Synthesized Silver and Titanium Dioxide Nanoparticles Against Rotavirus, Cytomegalovirus, and Human Papillomavirus
Background: Viral infections represent a major challenge in modern medicine, including diseases caused by human papillomavirus (HPV), cytomegalovirus (CMV), and rotavirus, which ar...
Antiviral Resistance Testing
Antiviral Resistance Testing
Abstract
The number of antiviral drugs approved for clinical use has dramatically increased in the past 25 years. However, the us...
Prophylactic antiviral therapy and all-cause mortality in cancer patients with hepatitis B e antigen-negative chronic hepatitis B virus infection receiving immunosuppressive therapy
Prophylactic antiviral therapy and all-cause mortality in cancer patients with hepatitis B e antigen-negative chronic hepatitis B virus infection receiving immunosuppressive therapy
Abstract
Background
The survival benefits of prophylactic antiviral therapy for cancer patients with hepatitis B e antigen (HBeA...

